InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-2.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Frohlich Tom, Deputy Chief Executive. Officer active across 2 companies, notably Chinook Therapeutics, INC.. In total, 14 filings have been published. Breakdown: 1 buy · 2 sells. Total volume traded: €344k. Activity tracked since 24 September 2021. The latest transaction was disclosed on 12 February 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Frohlich Tom
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
78,750 shares0Common StockSEC:0001193125-26-052054:0
6,000 shares@ US$7.40100.0% of flowCommon StockSEC:0000950170-25-074496:0
Canonical exit: 14 Aug 2025 (T+90)
150,777 sharesCommon StockSEC:0001209191-23-045418:0
6,803 sharesCommon StockSEC:0001209191-23-009769:0
8,333 sharesCommon StockSEC:0001209191-23-006375:0
10,000 shares@ US$0.420.6% of flowCommon StockSEC:0001209191-22-061442:0
10,000 shares@ US$0.420.7% of flowCommon StockSEC:0001209191-22-056210:0
13,582 sharesCommon StockSEC:0001209191-22-053304:0
6,801 sharesCommon StockSEC:0001209191-22-009560:0
6,230 shares@ US$15.4825.6% of flowCommon StockSEC:0001209191-21-064364:0
15,000 shares@ US$0.421.7% of flowCommon StockSEC:0001209191-21-063790:0
13,580 sharesCommon StockSEC:0001209191-21-060114:0
20,000 shares@ US$0.422.2% of flowCommon StockSEC:0001209191-21-057937:0
20,000 shares@ US$13.0068.0% of flowCommon StockSEC:0001209191-21-057713:0
14 of 14 declarations
About Frohlich Tom
Frohlich Tom is Directeur Général Adjoint, Responsable des Opérations. He has 14 filings in total, and across the sampled recent filings from 2021-09-24 to 2026-02-13, the reported volumes are 39669 in buys and 304630 in sells, with a modal transaction nature of Levée d'options. The companies mentioned are Chinook Therapeutics, INC. and Jade Biosciences, Inc.
